Joerg Kumbrink
Vice-head, Research Associate (previously held)
University of Munich
Pathology
Molecular Pathology




Postdoctoral Associate (previously held)
Boston University Chobanian & Avedisian School of Medicine
Biochemistry & Cell Biology


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Han Y, Koehler VF, Nagarajah J, Schmohl KA, Stauss C, Schwenk N, Spellerberg R, Kitzberger C, Kumbrink J, Zach C, Steiger K, Morris JC, Weber WA, Bartenstein P, Ziegler SI, Nelson PJ, Spitzweg C. TGF-ß1-based restoration of sodium iodide symporter expression in radioiodine-refractory differentiated thyroid cancer via engineered MSCs. Mol Ther. 2025 Dec 03; 33(12):6130-6145. PMID: 41109953
     
  2. Pesch G, Piseddu I, Gaertig J, Kramer N, Kramer R, Schulz TU, Zwiebel M, Ledderose S, Retzlaff J, Eckstein M, Schett G, Kammerbauer C, Schmitt C, Kumbrink J, Erdmann M, Kruis W, Dougan M, Mayerle J, French LE, Vera J, Nordmann TM, Mann M, Klauschen F, Anz D, Heinzerling L. Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor-Induced Colitis Compared with Ulcerative Colitis. Cancer Immunol Res. 2025 Jul 02; 13(7):1053-1069. PMID: 40249283
     
  3. Meier-Schiesser B, Zecha C, Zierold S, Kolm I, Röckel M, Fröhlich W, Mittag N, Schmitt C, Kumbrink J, Hassel JC, Berking C, Nashan D, French LE, Vera-González J, Dummer R, Kerl-French K, Heinzerling L. Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level. JAAD Int. 2024 Jun; 15:157-164. PMID: 38882039; PMCID: PMC11180371; DOI: 10.1016/j.jdin.2023.11.013;
     
  4. Dewenter I, Kumbrink J, Poxleitner P, Smolka W, Liokatis P, Fliefel R, Otto S, Obermeier KT. New insights into redox-related risk factors and therapeutic targets in oral squamous cell carcinoma. Oral Oncol. 2023 Dec; 147:106573. PMID: 37951115
     
  5. Koehler VF, Achterfeld J, Sandner N, Koch C, Wiegmann JP, Ivanyi P, Käsmann L, Pusch R, Wolf D, Chirica M, Knösel T, Demes MC, Kumbrink J, Vogl TJ, Meyer G, Spitzweg C, Bojunga J, Kroiss M. NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer. J Cancer Res Clin Oncol. 2023 Nov; 149(15):14035-14043. PMID: 37548775; PMCID: PMC10590332; DOI: 10.1007/s00432-023-05134-x;
     
  6. Moser C, Jurinovic V, Sagebiel-Kohler S, Ksienzyk B, Batcha AMN, Dufour A, Schneider S, Rothenberg-Thurley M, Sauerland CM, Görlich D, Berdel WE, Krug U, Mansmann U, Hiddemann W, Braess J, Spiekermann K, Greif PA, Vosberg S, Metzeler KH, Kumbrink J, Herold T. A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemia. Blood Adv. 2021 11 23; 5(22):4752-4761. PMID: 34535016; PMCID: PMC8759116; DOI: 10.1182/bloodadvances.2021004814;
     
  7. Sultova E, Westphalen CB, Jung A, Kumbrink J, Kirchner T, Mayr D, Rudelius M, Ormanns S, Heinemann V, Metzeler KH, Greif PA, Hester A, Mahner S, Harbeck N, Wuerstlein R. Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting. Diagnostics (Basel). 2021 Apr 20; 11(4). PMID: 33924134; PMCID: PMC8074310; DOI: 10.3390/diagnostics11040733;
     
  8. Sultova E, Westphalen CB, Jung A, Kumbrink J, Kirchner T, Mayr D, Rudelius M, Ormanns S, Heinemann V, Metzeler KH, Greif PA, Burges A, Trillsch F, Mahner S, Harbeck N, Wuerstlein R. NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU. Arch Gynecol Obstet. 2021 05; 303(5):1331-1345. PMID: 33277683; PMCID: PMC8053190; DOI: 10.1007/s00404-020-05881-z;
     
  9. Guenther M, Veninga V, Kumbrink J, Haas M, Westphalen CB, Kruger S, Heinemann V, Kirchner T, Boeck S, Jung A, Ormanns S. POLE gene hotspot mutations in advanced pancreatic cancer. J Cancer Res Clin Oncol. 2018 Nov; 144(11):2161-2166. PMID: 30194485
     
  10. Kumbrink J, de la Cueva A, Soni S, Sailer N, Kirsch KH. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo. Tumour Biol. 2016 Aug; 37(8):10665-73.View Related Profiles. PMID: 26867768; DOI: 10.1007/s13277-016-4902-8;
     
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 19 publications over 13 distinct years, with a maximum of 2 publications in 2012 and 2013 and 2015 and 2021 and 2023 and 2025

YearPublications
20051
20101
20111
20122
20132
20152
20161
20181
20201
20212
20232
20241
20252

Contact for Mentoring:

72 E. Concord St Silvio Conte (K)
Boston MA 02118
Google Map

617.638.4342
Download vCard

Kumbrink's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (161) concept(s)
_
Co-Authors
See all (7) people
_
Similar People
See all (60) people
_